Skip to main content

Table 1 Demographic information on MSA and control cases

From: Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity

Brain ID Age Gender PMI (hours) Disease duration (years)
MSA
 MSA1 61 Male 21 4
 MSA2 82 Male 8 7
 MSA3 74 Male 16 10
 MSA4 67 Male 11 8
 Mean 71 ± 7.8   14 ± 4.9 7.3 ± 2.2
Control
 Con1 69 Male 13.5 N/A
 Con2 85 Male 9 N/A
 Con3 65 Male 14.5 N/A
 Con4 88 Male 9 N/A
 Mean 76.8 ± 9.9   11.5 ± 2.5  
  1. PMI postmortem interval. There was no statistically significant difference in age and PMI between MSA and controls. Statistical test: Student’s t-test